![Michael M. Mueller](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael M. Mueller
Keine laufenden Positionen mehr
Karriereverlauf von Michael M. Mueller
Ehemalige bekannte Positionen von Michael M. Mueller
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VIRACTA THERAPEUTICS, INC. | General Counsel | 01.05.2020 | 01.01.2022 |
HISTOGEN INC. | General Counsel | 01.01.2013 | - |
Unternehmenssekretär | 01.01.2013 | - |
Ausbildung von Michael M. Mueller
University of Minnesota | Undergraduate Degree |
Thomas Jefferson School of Law | Graduate Degree |
San Diego State University | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
General Counsel | 2 |
Corporate Secretary | 1 |
Undergraduate Degree | 1 |
Sektoral
Consumer Services | 4 |
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
VIRACTA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Conatus Pharmaceuticals, Inc.
![]() Conatus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active selective caspase inhibitor, for diseases involving inflammasome pathways. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Michael M. Mueller
- Erfahrung